Duality Biotherapeutics, Inc. (9606.HK)
9606.HK Stock Price Chart
Explore Duality Biotherapeutics, Inc. interactive price chart. Choose custom timeframes to analyze 9606.HK price movements and trends.
9606.HK Company Profile
Discover essential business fundamentals and corporate details for Duality Biotherapeutics, Inc. (9606.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 Apr 2025
Employees
170.00
Website
https://www.dualitybiologics.comCEO
Zhong Yuan Zhu
Description
Duality Biotherapeutics, Inc. operates as a clinical stage company. It focuses on the development of next generation antibody-drug conjugate therapeutics and duality immune toxin antibody conjugate therapeutic. The company was founded by Zhu Zhong Yuan on July 3, 2019 and is headquartered in Shanghai, China.
9606.HK Financial Timeline
Browse a chronological timeline of Duality Biotherapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
9606.HK Stock Performance
Access detailed 9606.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.